[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hanss et al., 2021 - Google Patents

Mitochondrial and clearance impairment in p. D620N VPS35 patient‐derived neurons

Hanss et al., 2021

View PDF
Document ID
555416271778444735
Author
Hanss Z
Larsen S
Antony P
Mencke P
Massart F
Jarazo J
Schwamborn J
Barbuti P
Mellick G
Krüger R
Publication year
Publication venue
Movement Disorders

External Links

Snippet

Background VPS35 is part of the retromer complex and is responsible for the trafficking and recycling of proteins implicated in autophagy and lysosomal degradation, but also takes part in the degradation of mitochondrial proteins via mitochondria‐derived vesicles. The p …
Continue reading at movementdisorders.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Hanss et al. Mitochondrial and clearance impairment in p. D620N VPS35 patient‐derived neurons
Zhang et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model
Samarut et al. γ‐Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment
Inda et al. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
Xu et al. Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid β-protein oligomers
Vanderweyde et al. Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies
McMahon et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis
Abegg et al. Epileptiform activity in rat hippocampus strengthens excitatory synapses
Christie et al. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits
Sadeghi et al. Glutamatergic signaling at the vestibular hair cell calyx synapse
Guidi et al. Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of D own Syndrome
Shin et al. Multiple types of cerebellar target neurons and their circuitry in the vestibulo-ocular reflex
Oliveira et al. Neurofibromin is the major ras inactivator in dendritic spines
Wu et al. Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-β revealed by a novel fluorescence resonance energy transfer assay
Kroll et al. Endophilin‐A regulates presynaptic Ca2+ influx and synaptic vesicle recycling in auditory hair cells
VanGuilder et al. Hippocampal expression of myelin‐associated inhibitors is induced with age‐related cognitive decline and correlates with deficits of spatial learning and memory
Stork et al. Rising zinc: a significant cause of ischemic neuronal death in the CA1 region of rat hippocampus
Schepers et al. Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis
Baho et al. Neural activity and neurotransmission regulate the maturation of the innervation field of cortical GABAergic interneurons in an age-dependent manner
Arora et al. Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors
Dohn et al. The gain-of-function integrin β3 Pro33 variant alters the serotonin system in the mouse brain
Kopach et al. Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia
Huang et al. Cdk5-dependent phosphorylation of liprinα1 mediates neuronal activity-dependent synapse development
Dorner-Ciossek et al. Role of PDE9 in Cognition
Rudhard et al. Identification of 12/15-lipoxygenase as a regulator of axon degeneration through high-content screening